
Sign up to save your podcasts
Or
At least 5 agents that target the peroxisome proliferator-activated receptor (PPAR) are in clinical studies in primary biliary cholangitis (PBC). Are you aware of the latest data? Credit available for this activity expires: 2/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu
4.2
2222 ratings
At least 5 agents that target the peroxisome proliferator-activated receptor (PPAR) are in clinical studies in primary biliary cholangitis (PBC). Are you aware of the latest data? Credit available for this activity expires: 2/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu
127 Listeners
38 Listeners
13 Listeners
314 Listeners
854 Listeners
478 Listeners
688 Listeners
16 Listeners
283 Listeners
251 Listeners
3,324 Listeners
91 Listeners
1,085 Listeners
174 Listeners
512 Listeners
318 Listeners
59 Listeners
8 Listeners
245 Listeners
364 Listeners